Autism gene interaction map reveals 87% of links were unknown

A landmark study has mapped 1,881 protein interactions among 100 high-confidence autism risk genes, with 87 percent of those interactions being previously unreported. Published in Science, the research reveals how hundreds of different genetic mutations linked to autism spectrum disorder converge on shared biological networks, explaining the condition's complexity. The map, while extensive, covers only a fraction of the total biological picture, as hundreds more genes have been linked to the condition.

On average, each autism risk protein interacted with 11 others, forming a highly interconnected network. Different risk proteins tended to bind to the same central hubs. The team used AlphaFold, an AI system that predicts protein 3D shapes, to determine which proteins touched directly. Several of the identified genes overlap with those previously implicated in autism, developmental delay, intellectual disability, and schizophrenia.

Protein networks explain autism's biological complexity

Proteins rarely act alone, instead binding to form larger complexes. The research demonstrates that autism risk stems from these interconnected protein networks rather than single genes. To test this, the researchers introduced 54 specific genetic mutations from autistic patients into 30 of the risk proteins. These mutations altered 253 interactions, with some strengthening and others weakening. Completely different mutations often caused the exact same changes in the protein network.

For example, three different mutations in the FOXP1 gene caused its protein to lose its connection to FOXP4. In human forebrain organoids grown to study the impact, this loss caused the partner protein to attach to the wrong DNA sections. This led to premature maturation of brain cells, altered neuron proportions, and increased electrical activity. In separate tests of a central hub involving DCAF7 and DYRK1A, disrupting the complex impaired progenitor cell multiplication in human neural cells and resulted in smaller forebrain size in frog models.

Cross-disorder insights from OCD and tic study

A parallel study in Nature Neuroscience identifies 36 high-confidence genes for obsessive-compulsive disorder and chronic tic disorders, showing a similar network pattern. The study, built on over two decades of DNA collection from affected families, analyzed data from 3,964 people. It found rare protein-damaging mutations in approximately three to eight percent of affected individuals.

The high-confidence genes increase the likelihood of developing OCD or chronic tic disorders by 57 times on average, with some genes increasing risk by up to 210-fold. The study found that many of the identified genes exhibit greater connectivity with one another, suggesting they participate in interacting biological networks. OCD and chronic tic disorders affect an estimated one to two percent of the population, with significant symptom overlap.

From discovery to therapeutic targets

Researchers aim to translate these protein interaction maps into targeted therapies by identifying key convergent pathways. Nevan J. Krogan, a study co-author, noted the scale of the genetic challenge. "Over the past 15 years, large-scale sequencing studies have identified hundreds of genes associated with autism," Krogan said. The team has built a pipeline to apply their deep analysis approach more systematically and at a larger scale.

Their next goal is to identify which autism-associated mutations and biological pathways are most suitable for therapeutic development. Senior co-author Gary Heiman, along with colleague Jay Tischfield, contributed to the OCD and tic study. Other researchers, like Bradley, have called for the findings to be tested in mammalian developmental models where social and ASD-relevant behaviors can be examined. The work now focuses on identifying the most promising targets for drug development.